Tumor necrosis factor-α-activated mesenchymal stem cells promote endothelial progenitor cell homing and angiogenesis

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1832, Issue 12, 2013, Pages 2136-2144

  Kwon, Yang Woo ^a   Heo, Soon Chul ^a   Jeong, Geun Ok ^a   Yoon, Jung Won ^a   Mo, Won Min ^a   Lee, Mi Jeong ^a   Jang, Il Ho ^a   Kwon, Sang Mo ^a   Lee, Jung Sub ^a   Kim, Jae Ho ^a,b  

^a Pusan National University School of Medicine   (South Korea)

^b Pusan National University Yangsan Hospital   (South Korea)

Author keywords

Angiogenesis; Endothelial progenitor cells; Ischemia; Mesenchymal stem cells; Tumor necrosis factor

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 8; RECOMBINANT INTERLEUKIN 6; RECOMBINANT INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CELL HOMING; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; HINDLIMB; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LIMB ISCHEMIA; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PARACRINE SIGNALING; PERFUSION; PRIORITY JOURNAL; TISSUE REPAIR; UMBILICAL CORD BLOOD;

EID: 84883618391     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2013.08.002     Document Type: Article

References (42)

1. Beyar R. Controlling ischemic cardiovascular disease: from basic mechanisms to clinical management. Ann. N. Y. Acad. Sci. 2008, 1123:232-236.
2. Rutherford R.B., Baker J.D., Ernst C., Johnston K.W., Porter J.M., Ahn S., Jones D.N. Recommended standards for reports dealing with lower extremity ischemia: revised version. J. Vasc. Surg. 1997, 26:517-538.
3. Wollert K.C., Drexler H. Cell therapy for the treatment of coronary heart disease: a critical appraisal. Nat. Rev. Cardiol. 2010, 7:204-215.
4. Asahara T., Masuda H., Takahashi T., Kalka C., Pastore C., Silver M., Kearne M., Magner M., Isner J.M. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res. 1999, 85:221-228.
5. Hirata K., Li T.S., Nishida M., Ito H., Matsuzaki M., Kasaoka S., Hamano K. Autologous bone marrow cell implantation as therapeutic angiogenesis for ischemic hindlimb in diabetic rat model. Am. J. Physiol. Heart Circ. Physiol. 2003, 284:H66-H70.
6. Abdel-Latif A., Bolli R., Tleyjeh I.M., Montori V.M., Perin E.C., Hornung C.A., Zuba-Surma E.K., Al Mallah M., Dawn B. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch. Intern. Med. 2007, 167:989-997.
7. Schachinger V., Erbs S., Elsasser A., Haberbosch W., Hambrecht R., Holschermann H., Yu J., Corti R., Mathey D.G., Hamm C.W., Suselbeck T., Assmus B., Tonn T., Dimmeler S., Zeiher A.M. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N. Engl. J. Med. 2006, 355:1210-1221.
8. Vasa M., Fichtlscherer S., Aicher A., Adler K., Urbich C., Martin H., Zeiher A.M., Dimmeler S. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ. Res. 2001, 89:E1-E7.
9. da Silva M.L., Chagastelles P.C., Nardi N.B. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J. Cell Sci. 2006, 119:2204-2213.
10. Prockop D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997, 276:71-74.
11. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
12. Schaffler A., Buchler C. Concise review: adipose tissue-derived stromal cells-basic and clinical implications for novel cell-based therapies. Stem Cells 2007, 25:818-827.
13. Nauta A.J., Fibbe W.E. Immunomodulatory properties of mesenchymal stromal cells. Blood 2007, 110:3499-3506.
14. Ankrum J., Karp J.M. Mesenchymal stem cell therapy: two steps forward, one step back. Trends Mol. Med. 2010, 16:203-209.
15. Chamberlain G., Fox J., Ashton B., Middleton J. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 2007, 25:2739-2749.
16. Phinney D.G., Prockop D.J. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair-current views. Stem Cells 2007, 25:2896-2902.
17. Williams A.R., Hare J.M. Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circ. Res. 2011, 109:923-940.
18. Lee J.W., Fang X., Krasnodembskaya A., Howard J.P., Matthay M.A. Concise review: mesenchymal stem cells for acute lung injury: role of paracrine soluble factors. Stem Cells 2011, 29:913-919.
19. Ranganath S.H., Levy O., Inamdar M.S., Karp J.M. Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. Cell Stem Cell 2012, 10:244-258.
20. Locksley R.M., Killeen N., Lenardo M.J. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001, 104:487-501.
21. Jiang B., Liao R. The paradoxical role of inflammation in cardiac repair and regeneration. J. Cardiovasc. Transl. Res. 2010, 3:410-416.
22. Goukassian D.A., Qin G., Dolan C., Murayama T., Silver M., Curry C., Eaton E., Luedemann C., Ma H., Asahara T., Zak V., Mehta S., Burg A., Thorne T., Kishore R., Losordo D.W. Tumor necrosis factor-alpha receptor p75 is required in ischemia-induced neovascularization. Circulation 2007, 115:752-762.
23. Lee M.J., Kim J., Kim M.Y., Bae Y.S., Ryu S.H., Lee T.G., Kim J.H. Proteomic analysis of tumor necrosis factor-alpha-induced secretome of human adipose tissue-derived mesenchymal stem cells. J. Proteome Res. 2010, 9:1754-1762.
24. Heo S.C., Jeon E.S., Lee I.H., Kim H.S., Kim M.B., Kim J.H. Tumor necrosis factor-alpha-activated human adipose tissue-derived mesenchymal stem cells accelerate cutaneous wound healing through paracrine mechanisms. J. Invest. Dermatol. 2011, 131:1559-1567.
25. Jeon E.S., Moon H.J., Lee M.J., Song H.Y., Kim Y.M., Bae Y.C., Jung J.S., Kim J.H. Sphingosylphosphorylcholine induces differentiation of human mesenchymal stem cells into smooth-muscle-like cells through a TGF-{beta}-dependent mechanism. J. Cell Sci. 2006, 119:4994-5005.
26. Shin S.H., Kim J., Heo S.C., Kwon Y.W., Kim Y.M., Kim I.S., Lee T.G., Kim J.H. Proteomic identification of betaig-h3 as a lysophosphatidic acid-induced secreted protein of human mesenchymal stem cells: paracrine activation of A549 lung adenocarcinoma cells by betaig-h3. Mol. Cell. Proteomics 2012, 11:M111.
27. Kalka C., Masuda H., Takahashi T., Kalka-Moll W.M., Silver M., Kearney M., Li T., Isner J.M., Asahara T. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:3422-3427.
28. Gertz K., Kronenberg G., Kalin R.E., Baldinger T., Werner C., Balkaya M., Eom G.D., Hellmann-Regen J., Krober J., Miller K.R., Lindauer U., Laufs U., Dirnagl U., Heppner F.L., Endres M. Essential role of interleukin-6 in post-stroke angiogenesis. Brain 2012, 135:1964-1980.
29. Gregory A.D., Capoccia B.J., Woloszynek J.R., Link D.C. Systemic levels of G-CSF and interleukin-6 determine the angiogenic potential of bone marrow resident monocytes. J. Leukoc. Biol. 2010, 88:123-131.
30. McClintock J.Y., Wagner E.M. Role of IL-6 in systemic angiogenesis of the lung. J. Appl. Physiol. 2005, 99:861-866.
31. Hernandez-Rodriguez J., Segarra M., Vilardell C., Sanchez M., Garcia-Martinez A., Esteban M.J., Grau J.M., Urbano-Marquez A., Colomer D., Kleinman H.K., Cid M.C. Elevated production of interleukin-6 is associated with a lower incidence of disease-related ischemic events in patients with giant-cell arteritis: angiogenic activity of interleukin-6 as a potential protective mechanism. Circulation 2003, 107:2428-2434.
32. Fan Y., Ye J., Shen F., Zhu Y., Yeghiazarians Y., Zhu W., Chen Y., Lawton M.T., Young W.L., Yang G.Y. Interleukin-6 stimulates circulating blood-derived endothelial progenitor cell angiogenesis in vitro. J. Cereb. Blood Flow Metab. 2008, 28:90-98.
33. Baggiolini M., Clark-Lewis I. Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Lett. 1992, 307:97-101.
34. Kukielka G.L., Smith C.W., LaRosa G.J., Manning A.M., Mendoza L.H., Daly T.J., Hughes B.J., Youker K.A., Hawkins H.K., Michael L.H. Interleukin-8 gene induction in the myocardium after ischemia and reperfusion in vivo. J. Clin. Invest. 1995, 95:89-103.
35. Li A., Dubey S., Varney M.L., Dave B.J., Singh R.K. IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J. Immunol. 2003, 170:3369-3376.
36. Koch A.E., Polverini P.J., Kunkel S.L., Harlow L.A., DiPietro L.A., Elner V.M., Elner S.G., Strieter R.M. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992, 258:1798-1801.
37. Kocher A.A., Schuster M.D., Bonaros N., Lietz K., Xiang G., Martens T.P., Kurlansky P.A., Sondermeijer H., Witkowski P., Boyle A., Homma S., Wang S.F., Itescu S. Myocardial homing and neovascularization by human bone marrow angioblasts is regulated by IL-8/Gro CXC chemokines. J. Mol. Cell. Cardiol. 2006, 40:455-464.
38. Hsiao S.T., Asgari A., Lokmic Z., Sinclair R., Dusting G.J., Lim S.Y., Dilley R.J. Comparative analysis of paracrine factor expression in human adult mesenchymal stem cells derived from bone marrow, adipose, and dermal tissue. Stem Cells Dev. 2012, 21:2189-2203.
39. Nakagami H., Morishita R., Maeda K., Kikuchi Y., Ogihara T., Kaneda Y. Adipose tissue-derived stromal cells as a novel option for regenerative cell therapy. J. Atheroscler. Thromb. 2006, 13:77-81.
40. Kinnaird T., Stabile E., Burnett M.S., Lee C.W., Barr S., Fuchs S., Epstein S.E. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ. Res. 2004, 94:678-685.
41. Wu Y., Chen L., Scott P.G., Tredget E.E. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells 2007, 25:2648-2659.
42. Wang M., Crisostomo P.R., Herring C., Meldrum K.K., Meldrum D.R. Human progenitor cells from bone marrow or adipose tissue produce VEGF, HGF, and IGF-I in response to TNF by a p38 MAPK-dependent mechanism. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006, 291:R880-R884.